{"gene":"NDUFA10","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":2005,"finding":"Phosphorylation of NDUFA10 (the 42-kDa subunit of mitochondrial Complex I) was mapped by tandem mass spectrometry to serine-59 within the peptide LITVDGNICSGKSK (residues 47–60) in bovine heart mitochondria.","method":"2D gel electrophoresis combined with tandem mass spectrometry (MS/MS), confirmed by synthetic peptide","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct MS/MS identification with synthetic peptide confirmation","pmids":["15848193"],"is_preprint":false},{"year":2008,"finding":"Two-dimensional electrophoresis and extensive MS/MS analysis of rat brain NDUFA10 identified a D/N substitution at position 120 (from a 353A/G coding transition) as the biochemical difference between two major isoforms, and found 33 distinct post-translational modifications at 59 residues, including methylations of R, K, and H and likely acetylations at the C-terminal region; residues C67, H149, and H322 were particularly targeted, suggesting functional importance.","method":"2-DE combined with MS/MS; synthetic variant verification","journal":"Proteomics","confidence":"Medium","confidence_rationale":"Tier 1 method (MS/MS) but single-lab characterization with no functional mutagenesis follow-up","pmids":["18442173"],"is_preprint":false},{"year":2010,"finding":"Compound-heterozygous mutations in NDUFA10 (one disrupting the start codon, one causing an amino acid substitution) cause decreased Complex I amount, activity, and disturbed assembly in patient fibroblasts, establishing NDUFA10 as an accessory subunit required for proper Complex I assembly and activity.","method":"Patient fibroblast biochemical assays (BN-PAGE, activity measurements, immunoblotting); genetic sequencing","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO/patient cells with defined biochemical phenotype, single lab","pmids":["21150889"],"is_preprint":false},{"year":2014,"finding":"PINK1 phosphorylates NDUFA10 at serine-250, and this phosphorylation is required for ubiquinone reduction by Complex I. Loss of PINK1 leads to specific loss of Ser-250 phosphorylation on NdufA10, causing reduced Complex I reductive activity and decreased mitochondrial membrane potential. Phosphomimetic NdufA10 (S250D) rescues Complex I deficits, ATP synthesis, mitochondrial depolarization, and synaptic transmission defects in PINK1-null Drosophila and patient-derived cells.","method":"Phosphoproteomics of Complex I from Pink1−/− mouse liver/brain; phosphomimetic rescue in knockout cells and Drosophila; ATP synthesis and membrane potential assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — phosphoproteomics, multiple orthogonal rescue assays, in vivo and patient-cell validation, replicated across models","pmids":["24652937"],"is_preprint":false},{"year":2014,"finding":"In Drosophila pink1 mutants, transgenic overexpression of ND42 (NDUFA10 ortholog) or its co-chaperone sicily restores Complex I activity and partially rescues locomotion and mitochondrial defects in flight muscles, independent of mitophagy; this rescue does not strictly require Ser-250 phosphorylation. NDUFA10 knockdown only minimally affects CCCP-induced mitophagy in human cells, and NDUFA10 overexpression does not restore Parkin mitochondrial translocation upon PINK1 loss, indicating the rescue acts via Complex I activity rather than the Parkin/mitophagy pathway.","method":"Drosophila transgenic overexpression; RNAi screen in Drosophila cells; CCCP-induced mitophagy assay in human cells; Complex I activity assays; behavioral assays","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo and cell-based methods, genetic epistasis between PINK1 and parkin pathways established","pmids":["25412178"],"is_preprint":false},{"year":2016,"finding":"CRISPR/Cas9 knockout of NDUFA10 in human cells results in loss of assembled, functional Complex I, demonstrating that NDUFA10 is strictly required for Complex I assembly; quantitative proteomics showed that loss of NDUFA10 destabilizes subunits in the same structural module.","method":"CRISPR/Cas9 gene editing in human cell lines; BN-PAGE; quantitative proteomics","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — genome editing with orthogonal biochemical and proteomic validation","pmids":["27626371"],"is_preprint":false},{"year":2022,"finding":"NDUFA10 harbors a deoxyribonucleoside kinase (dNK) domain that tightly binds dGTP; mutation of this domain (E160A/R161A) reduces dGTP binding in vitro and lowers mitochondrial dGTP content by ~50% without disrupting Complex I assembly or activity, establishing NDUFA10 as the primary determinant of mitochondrial dGTP levels and linking oxidative metabolism to mitochondrial DNA maintenance.","method":"Site-directed mutagenesis in HEK-293T cells; in vitro dGTP-binding assay; measurement of mitochondrial dNTP pools by HPLC; BN-PAGE for Complex I assembly","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with in vitro binding assay and cellular dNTP quantification; assembly preserved as control","pmids":["35739187"],"is_preprint":false},{"year":2022,"finding":"Benzo[a]pyrene (via its metabolite BPDE) downregulates NDUFA10 expression in mouse Leydig cells through PPARα activation, and NDUFA10-mediated mitochondrial dysfunction perturbs testosterone synthesis; NDUFA10 knockdown recapitulates mitochondrial impairment and steroidogenesis perturbation in TM3 cells.","method":"In vivo mouse model; transcriptome profiling; in vitro siRNA knockdown in TM3 cells; mitochondrial function assays; in silico toxicological analyses","journal":"Ecotoxicology and environmental safety","confidence":"Medium","confidence_rationale":"Tier 2–3 — knockdown with functional readout (testosterone, mitochondrial morphology) in multiple systems, but mechanism inferred partly from expression data","pmids":["36108438"],"is_preprint":false},{"year":2024,"finding":"CAV3 (caveolin-3) physically interacts with NDUFA10 as shown by co-immunoprecipitation; CAV3 overexpression reduces lysosomal degradation of NDUFA10, restores Complex I activity, and ameliorates mitochondrial dysfunction in diabetic cardiomyopathy models, while loss of CAV3 exacerbates NDUFA10 degradation and Complex I impairment.","method":"LC-MS/MS interactome; co-immunoprecipitation; cardiac-specific AAV overexpression in db/db mice; Complex I activity assays; mitochondrial function assays","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — reciprocal Co-IP plus in vivo rescue, single lab","pmids":["38671439"],"is_preprint":false},{"year":2024,"finding":"Neuroglobin (Ngb) physically interacts with NDUFA10 (confirmed by co-immunoprecipitation in MN9D cells); Ngb overexpression rescues Complex I activity, restores mitochondrial membrane potential and NAD+/NADH ratios, reduces ROS, and inhibits caspase-9-mediated apoptosis in an MPP+-induced Parkinson's disease cell model, while Ngb knockdown worsens these parameters.","method":"Co-immunoprecipitation; lentiviral overexpression and siRNA knockdown; ELISA-based Complex I activity; flow cytometry (apoptosis); MMP and ROS measurements","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus multiple functional readouts, single lab","pmids":["39454716"],"is_preprint":false},{"year":2024,"finding":"PINK1 regulates ATP production by phosphorylating the Complex I subunit NdufA10; the PD-associated PINK1-G411S mutant shows increased kinase stability due to altered ATP-binding pocket rigidity (revealed by molecular dynamics), and enhances mitochondrial-linked functions including NdufA10 phosphorylation.","method":"Molecular dynamics simulation; biochemical characterization of PINK1 mutants; mitochondrial function assays","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3–4 — preprint; structural inference from molecular dynamics with partial experimental validation","pmids":["bio_10.1101_2024.06.28.601304"],"is_preprint":true},{"year":2025,"finding":"Viral knockdown of NDUFA10 in the medial prefrontal cortex (mPFC) of mice reduces ATP levels and increases sevoflurane-induced burst suppression ratio and EEG suppression time, while exogenous ATP administration reverses these effects, establishing that NDUFA10-driven energy metabolism in the mPFC is required for normal cortical excitability under anesthesia.","method":"Site-specific viral knockdown; in vivo fiber-optic ATP recording; EEG recording; mRNA sequencing; ATP administration rescue","journal":"CNS neuroscience & therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 — site-specific in vivo KD with defined electrophysiological and metabolic phenotype and ATP rescue","pmids":["40415484"],"is_preprint":false}],"current_model":"NDUFA10 is an accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that is strictly required for Complex I assembly and ubiquinone-reductive activity; its activity is regulated by PINK1-mediated phosphorylation at Ser-250, which is necessary for ubiquinone reduction, and its deoxyribonucleoside kinase (dNK) domain tightly sequesters mitochondrial dGTP to regulate dNTP pool homeostasis; NDUFA10 also interacts with CAV3 and neuroglobin, which protect it from lysosomal degradation and support Complex I-dependent ATP synthesis and mitochondrial membrane integrity."},"narrative":{"teleology":[{"year":2005,"claim":"Identification that NDUFA10 is a phosphoprotein established post-translational regulation of a Complex I accessory subunit, raising the question of which kinase(s) and which site(s) are functionally relevant.","evidence":"2D gel electrophoresis and tandem MS/MS on bovine heart mitochondrial Complex I, with synthetic peptide confirmation of phospho-Ser-59","pmids":["15848193"],"confidence":"High","gaps":["The responsible kinase was not identified","Functional consequence of Ser-59 phosphorylation on Complex I activity was not tested","Relevance of this site in non-bovine systems was unknown"]},{"year":2010,"claim":"Establishing that patient mutations in NDUFA10 cause deficient Complex I assembly and activity demonstrated that NDUFA10, although an accessory subunit, is indispensable for Complex I biogenesis.","evidence":"Biochemical analysis (BN-PAGE, activity assays, immunoblotting) of fibroblasts from a patient with compound-heterozygous NDUFA10 mutations","pmids":["21150889"],"confidence":"Medium","gaps":["Single family study; genetic rescue was not performed","The specific assembly step blocked by NDUFA10 loss was not resolved"]},{"year":2014,"claim":"Discovery that PINK1 phosphorylates NDUFA10 at Ser-250 and that this event is required for ubiquinone reduction provided a direct mechanistic link between PINK1-associated Parkinson's disease and Complex I dysfunction.","evidence":"Phosphoproteomics of Complex I from Pink1−/− mouse tissues; phosphomimetic S250D rescue of Complex I activity, ATP synthesis, and neurotransmission in PINK1-null Drosophila and patient cells","pmids":["24652937","25412178"],"confidence":"High","gaps":["Whether Ser-250 phosphorylation is the sole functional PINK1 target on Complex I or one of several","Structural basis of how phospho-Ser-250 enables ubiquinone reduction was not determined","Degree to which NDUFA10 rescue acts independently of the Parkin/mitophagy axis was debated across studies"]},{"year":2016,"claim":"CRISPR knockout confirmed that NDUFA10 is strictly required for Complex I assembly in human cells and that its loss destabilizes subunits within the same structural module, resolving ambiguity from patient studies.","evidence":"CRISPR/Cas9 knockout in human cell lines with BN-PAGE and quantitative proteomics","pmids":["27626371"],"confidence":"High","gaps":["Which specific assembly intermediate accumulates upon NDUFA10 loss was not fully resolved","Potential extra-Complex I functions were not addressed"]},{"year":2022,"claim":"Identification of a deoxyribonucleoside kinase domain in NDUFA10 that tightly binds dGTP and controls ~50% of mitochondrial dGTP content revealed an unexpected moonlighting function linking oxidative metabolism to mtDNA precursor homeostasis.","evidence":"Site-directed mutagenesis (E160A/R161A) in HEK-293T cells; in vitro dGTP-binding assay; HPLC measurement of mitochondrial dNTP pools; BN-PAGE confirming intact Complex I assembly","pmids":["35739187"],"confidence":"High","gaps":["Whether NDUFA10's dNK domain possesses catalytic kinase activity or acts solely as a sequestering/storage site","Impact of dGTP-binding mutations on mtDNA replication fidelity or copy number in vivo","Relationship between phosphorylation at Ser-250 and dGTP binding"]},{"year":2024,"claim":"Identification of CAV3 and neuroglobin as physical interactors of NDUFA10 that protect it from degradation and sustain Complex I function expanded the regulatory network controlling NDUFA10 stability in disease contexts (diabetic cardiomyopathy and Parkinson's models).","evidence":"Co-immunoprecipitation and LC-MS/MS interactomics; AAV-mediated CAV3 overexpression in db/db mouse hearts; Ngb overexpression/knockdown with Complex I activity and apoptosis readouts in MN9D cells","pmids":["38671439","39454716"],"confidence":"Medium","gaps":["Binding interfaces on NDUFA10 for CAV3 and neuroglobin are unmapped","Whether these interactions occur on assembled Complex I or on free NDUFA10","Independent replication needed for both interactions"]},{"year":2025,"claim":"In vivo knockdown of NDUFA10 in mouse medial prefrontal cortex demonstrated that NDUFA10-dependent ATP production is required for normal cortical excitability, extending its physiological relevance to brain circuit function.","evidence":"Site-specific viral knockdown in mPFC; in vivo ATP fiber-optic recording; EEG; ATP rescue","pmids":["40415484"],"confidence":"Medium","gaps":["Whether the phenotype is specific to NDUFA10 or generalizes to any Complex I subunit loss","Long-term neurological consequences of mPFC NDUFA10 depletion not assessed"]},{"year":null,"claim":"Key unresolved questions include the structural basis of how Ser-250 phosphorylation activates ubiquinone reduction, whether the dNK domain possesses catalytic kinase activity or functions purely as a dGTP-sequestering module, and how NDUFA10's dual roles in electron transfer and dNTP homeostasis are coordinated.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of NDUFA10 with bound dGTP or phospho-Ser-250 exists","Catalytic vs. sequestering function of the dNK domain unresolved","Coordination between phosphorylation state and dGTP binding not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[6]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[2,5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2,3,5,6]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3,5,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,3]}],"complexes":["Mitochondrial Complex I (NADH:ubiquinone oxidoreductase)"],"partners":["PINK1","CAV3","NGB"],"other_free_text":[]},"mechanistic_narrative":"NDUFA10 is an accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that is strictly required for Complex I assembly, ubiquinone-reductive activity, and mitochondrial ATP production. PINK1 phosphorylates NDUFA10 at Ser-250, and this modification is necessary for Complex I ubiquinone reduction; phosphomimetic NDUFA10 rescues Complex I deficits, ATP synthesis, and synaptic transmission in PINK1-null Drosophila and patient-derived cells [PMID:24652937, PMID:25412178]. Beyond its Complex I structural role, NDUFA10 harbors a deoxyribonucleoside kinase domain that sequesters dGTP and serves as the primary determinant of mitochondrial dGTP levels, linking oxidative phosphorylation to mitochondrial DNA precursor homeostasis [PMID:35739187]. Compound-heterozygous loss-of-function mutations in NDUFA10 cause mitochondrial Complex I deficiency in patients [PMID:21150889]."},"prefetch_data":{"uniprot":{"accession":"O95299","full_name":"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial","aliases":["Complex I-42kD","CI-42kD","NADH-ubiquinone oxidoreductase 42 kDa subunit"],"length_aa":355,"mass_kda":40.8,"function":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/O95299/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFA10","classification":"Not Classified","n_dependent_lines":328,"n_total_lines":1208,"dependency_fraction":0.271523178807947},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTR2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NDUFA10","total_profiled":1310},"omim":[{"mim_id":"618243","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22","url":"https://www.omim.org/entry/618243"},{"mim_id":"608309","title":"PTEN-INDUCED KINASE 1; PINK1","url":"https://www.omim.org/entry/608309"},{"mim_id":"603843","title":"NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B10; NDUFB10","url":"https://www.omim.org/entry/603843"},{"mim_id":"603840","title":"NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B4; NDUFB4","url":"https://www.omim.org/entry/603840"},{"mim_id":"603835","title":"NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A10; NDUFA10","url":"https://www.omim.org/entry/603835"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"tongue","ntpm":309.9}],"url":"https://www.proteinatlas.org/search/NDUFA10"},"hgnc":{"alias_symbol":["CI-42k"],"prev_symbol":[]},"alphafold":{"accession":"O95299","domains":[{"cath_id":"3.40.50.300","chopping":"55-323","consensus_level":"medium","plddt":90.1487,"start":55,"end":323}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95299","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95299-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95299-F1-predicted_aligned_error_v6.png","plddt_mean":84.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFA10","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFA10"},"sequence":{"accession":"O95299","fasta_url":"https://rest.uniprot.org/uniprotkb/O95299.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95299/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95299"}},"corpus_meta":[{"pmid":"24652937","id":"PMC_24652937","title":"PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/24652937","citation_count":274,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21150889","id":"PMC_21150889","title":"NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/21150889","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25412178","id":"PMC_25412178","title":"The complex I subunit NDUFA10 selectively rescues Drosophila pink1 mutants through a mechanism independent of mitophagy.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25412178","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15848193","id":"PMC_15848193","title":"Mass spectrometric identification of a novel phosphorylation site in subunit NDUFA10 of bovine mitochondrial complex I.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15848193","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37373264","id":"PMC_37373264","title":"An Exploration of the Coherent Effects between METTL3 and NDUFA10 on Alzheimer's Disease.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37373264","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36108438","id":"PMC_36108438","title":"Benzo[a]pyrene inhibits testosterone biosynthesis via NDUFA10-mediated mitochondrial compromise in mouse Leydig cells: Integrating experimental and in silico toxicological approaches.","date":"2022","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/36108438","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35739187","id":"PMC_35739187","title":"Most mitochondrial dGTP is tightly bound to respiratory complex I through the NDUFA10 subunit.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35739187","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18442173","id":"PMC_18442173","title":"Mass spectrometric characterization of mitochondrial complex I NDUFA10 variants.","date":"2008","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/18442173","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38671439","id":"PMC_38671439","title":"CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38671439","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28247337","id":"PMC_28247337","title":"Widening the Heterogeneity of Leigh Syndrome: Clinical, Biochemical, and Neuroradiologic Features in a Patient Harboring a NDUFA10 Mutation.","date":"2017","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/28247337","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39454716","id":"PMC_39454716","title":"Neuroglobin protects dopaminergic neurons in a Parkinson's cell model by interacting with mitochondrial complex NDUFA10.","date":"2024","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39454716","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40415484","id":"PMC_40415484","title":"NDUFA10-Mediated ATP Reduction in Medial Prefrontal Cortex Exacerbates Burst Suppression in Aged Mice.","date":"2025","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/40415484","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41944119","id":"PMC_41944119","title":"NDUFA10: An Emerging Oncogenic Driver of Metastasis in Lung Adenocarcinoma.","date":"2026","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/41944119","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.06.28.601304","title":"PINK1-G411S mutant increases kinase stability and enhances mitochondrial-linked functions","date":"2024-07-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.28.601304","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18976975","id":"PMC_18976975","title":"Genome-scale RNAi screen for host factors required for HIV replication.","date":"2008","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18976975","citation_count":627,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12665801","id":"PMC_12665801","title":"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12665801","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27626371","id":"PMC_27626371","title":"Accessory subunits are integral for assembly and function of human mitochondrial complex I.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/27626371","citation_count":450,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28844695","id":"PMC_28844695","title":"Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28844695","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22046132","id":"PMC_22046132","title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.","date":"2011","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/22046132","citation_count":341,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35063084","id":"PMC_35063084","title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.","date":"2022","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/35063084","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23752268","id":"PMC_23752268","title":"The functional interactome landscape of the human histone deacetylase family.","date":"2013","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/23752268","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27499296","id":"PMC_27499296","title":"Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499296","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30030361","id":"PMC_30030361","title":"Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes.","date":"2018","source":"Essays in biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30030361","citation_count":206,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31995728","id":"PMC_31995728","title":"AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31995728","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30554943","id":"PMC_30554943","title":"Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30554943","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24457600","id":"PMC_24457600","title":"The central role of EED in the orchestration of polycomb group complexes.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24457600","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8210,"output_tokens":2393,"usd":0.030263},"stage2":{"model":"claude-opus-4-6","input_tokens":5701,"output_tokens":2203,"usd":0.12537},"total_usd":0.343729,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":19967,"output_tokens":3073,"usd":0.052998},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6703,"output_tokens":2262,"usd":0.135098}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"PINK1 phosphorylates serine-250 of NDUFA10 (NdufA10), and this phosphorylation is required for ubiquinone reduction by mitochondrial complex I; loss of PINK1 leads to loss of this phosphorylation, causing complex I reductive activity deficits and decreased mitochondrial membrane potential. Phosphomimetic NdufA10 rescues these deficits in mouse knockout cells and Drosophila pink1-null mutants.\",\n      \"method\": \"Phosphoproteomics of complex I from Pink1(-/-) mouse liver and brain; phosphomimetic rescue in knockout cells and Drosophila; ATP synthesis assays in patient-derived cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (phosphoproteomics, mutagenesis, in vivo rescue, patient cells), replicated across species\",\n      \"pmids\": [\"24652937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NDUFA10 is phosphorylated at serine-59 (bovine serine-59; in the peptide LITVDGNICSGSSK) within bovine heart mitochondrial complex I, as identified by tandem mass spectrometry.\",\n      \"method\": \"Tandem mass spectrometry of purified bovine heart complex I; confirmed by synthetic peptide\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct mass spectrometric site identification with synthetic peptide confirmation\",\n      \"pmids\": [\"15848193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NDUFA10 is an accessory subunit of mitochondrial complex I whose loss (via compound-heterozygous mutations including disruption of the start codon and an amino acid substitution) causes decreased complex I amount, activity, and disturbed complex I assembly in patient fibroblasts and muscle tissue, establishing it as necessary for complex I integrity.\",\n      \"method\": \"Patient fibroblast/muscle biochemistry; blue-native PAGE complex I assembly analysis; genetic screening of nuclear-encoded complex I subunits\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in patient cells with multiple biochemical readouts (activity, amount, assembly)\",\n      \"pmids\": [\"21150889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Overexpression of NDUFA10 (ND42) or its co-chaperone sicily in Drosophila pink1 mutants restores complex I activity and partially rescues locomotion and mitochondrial disruption in flight muscles, through a mechanism that does not require phosphorylation at Ser-250 and is independent of mitophagy. Knockdown of human NDUFA10 only minimally affects CCCP-induced mitophagy, and NDUFA10 overexpression does not restore Parkin mitochondrial translocation upon PINK1 loss.\",\n      \"method\": \"Transgenic Drosophila overexpression; complex I activity assays; flight and climbing assays; RNAi knockdown in human cells; CCCP-induced mitophagy assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic rescue with multiple phenotypic readouts plus human cell knockdown experiments\",\n      \"pmids\": [\"25412178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NDUFA10 contains a deoxyribonucleoside kinase (dNK) domain that tightly binds dGTP; mutation of the dNK domain (E160A/R161A) in HEK-293T cells preserves complex I assembly and activity but reduces dGTP-binding capacity in vitro and reduces mitochondrial dGTP content by ~50%, demonstrating that NDUFA10 is the primary reservoir of mitochondrial dGTP.\",\n      \"method\": \"Site-directed mutagenesis of dNK domain; in vitro dGTP binding assay; mitochondrial dNTP pool quantification; complex I assembly and activity assays in HEK-293T cells\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with in vitro binding assay and cellular dNTP pool measurement\",\n      \"pmids\": [\"35739187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CAV3 (caveolin 3) physically interacts with NDUFA10 and protects it from lysosomal degradation; CAV3 overexpression restores mitochondrial complex I activity and improves mitochondrial function in diabetic cardiomyopathy models.\",\n      \"method\": \"LC-MS/MS proteomics; co-immunoprecipitation; CAV3 cardiac-specific overexpression in db/db mice; complex I activity assays\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal Co-IP and in vivo overexpression with functional readout, single lab\",\n      \"pmids\": [\"38671439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Neuroglobin (Ngb) physically interacts with NDUFA10 in MN9D neuroblastoma cells; Ngb overexpression restores complex I activity, mitochondrial membrane potential, and NAD+/NADH ratios while reducing apoptosis in an MPP+-based Parkinson's disease cell model.\",\n      \"method\": \"Co-immunoprecipitation in MN9D cells; lentiviral overexpression and siRNA knockdown; complex I ELISA activity assay; mitochondrial membrane potential measurement; flow cytometry apoptosis assay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP plus functional overexpression/knockdown experiments, single lab\",\n      \"pmids\": [\"39454716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Two abundant NDUFA10 protein isoforms exist in rat brain, differing by a D/N substitution at position 120. Mass spectrometric analysis identified 33 post-translational modifications at 59 residues, with positions C67, H149, and H322 being particularly heavily modified, and C-terminal R, K, and H methylations and K acetylations identified, suggesting regulatory roles.\",\n      \"method\": \"2D gel electrophoresis combined with tandem mass spectrometry of rat brain mitochondria\",\n      \"journal\": \"Proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method (MS characterization) but functional consequence of modifications not experimentally validated\",\n      \"pmids\": [\"18442173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Site-specific viral knockdown of NDUFA10 in the medial prefrontal cortex of mice increases sevoflurane-induced burst suppression and reduces ATP levels, while exogenous ATP attenuates these changes, placing NDUFA10-driven ATP production as a mechanism regulating anesthesia-induced burst suppression in aged mice.\",\n      \"method\": \"AAV-mediated site-specific knockdown; EEG burst suppression analysis; in vivo fiber-optic ATP recording; mRNA sequencing\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo viral knockdown with electrophysiological and metabolic readouts, single lab\",\n      \"pmids\": [\"40415484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PINK1 regulates ATP production by phosphorylating the complex I subunit NdufA10; the PINK1-G411S mutant exhibits enhanced kinase stability and function, providing a structural explanation via molecular dynamics for how mutations in the ATP-binding pocket increase rigidity and kinase activity.\",\n      \"method\": \"Molecular dynamics simulation; biochemical characterization of PINK1 mutants\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational modeling with limited experimental validation, preprint\",\n      \"pmids\": [\"bio_10.1101_2024.06.28.601304\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"NDUFA10 is an accessory subunit of mitochondrial complex I that is required for complex I assembly, stability, and ubiquinone reduction; it is phosphorylated at Ser-250 by PINK1 (a modification necessary for complex I reductive activity), contains a deoxyribonucleoside kinase domain that sequesters the majority of mitochondrial dGTP, and interacts with partners including CAV3 and neuroglobin to modulate complex I activity and mitochondrial function.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Phosphorylation of NDUFA10 (the 42-kDa subunit of mitochondrial Complex I) was mapped by tandem mass spectrometry to serine-59 within the peptide LITVDGNICSGKSK (residues 47–60) in bovine heart mitochondria.\",\n      \"method\": \"2D gel electrophoresis combined with tandem mass spectrometry (MS/MS), confirmed by synthetic peptide\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct MS/MS identification with synthetic peptide confirmation\",\n      \"pmids\": [\"15848193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Two-dimensional electrophoresis and extensive MS/MS analysis of rat brain NDUFA10 identified a D/N substitution at position 120 (from a 353A/G coding transition) as the biochemical difference between two major isoforms, and found 33 distinct post-translational modifications at 59 residues, including methylations of R, K, and H and likely acetylations at the C-terminal region; residues C67, H149, and H322 were particularly targeted, suggesting functional importance.\",\n      \"method\": \"2-DE combined with MS/MS; synthetic variant verification\",\n      \"journal\": \"Proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method (MS/MS) but single-lab characterization with no functional mutagenesis follow-up\",\n      \"pmids\": [\"18442173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Compound-heterozygous mutations in NDUFA10 (one disrupting the start codon, one causing an amino acid substitution) cause decreased Complex I amount, activity, and disturbed assembly in patient fibroblasts, establishing NDUFA10 as an accessory subunit required for proper Complex I assembly and activity.\",\n      \"method\": \"Patient fibroblast biochemical assays (BN-PAGE, activity measurements, immunoblotting); genetic sequencing\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO/patient cells with defined biochemical phenotype, single lab\",\n      \"pmids\": [\"21150889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PINK1 phosphorylates NDUFA10 at serine-250, and this phosphorylation is required for ubiquinone reduction by Complex I. Loss of PINK1 leads to specific loss of Ser-250 phosphorylation on NdufA10, causing reduced Complex I reductive activity and decreased mitochondrial membrane potential. Phosphomimetic NdufA10 (S250D) rescues Complex I deficits, ATP synthesis, mitochondrial depolarization, and synaptic transmission defects in PINK1-null Drosophila and patient-derived cells.\",\n      \"method\": \"Phosphoproteomics of Complex I from Pink1−/− mouse liver/brain; phosphomimetic rescue in knockout cells and Drosophila; ATP synthesis and membrane potential assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — phosphoproteomics, multiple orthogonal rescue assays, in vivo and patient-cell validation, replicated across models\",\n      \"pmids\": [\"24652937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In Drosophila pink1 mutants, transgenic overexpression of ND42 (NDUFA10 ortholog) or its co-chaperone sicily restores Complex I activity and partially rescues locomotion and mitochondrial defects in flight muscles, independent of mitophagy; this rescue does not strictly require Ser-250 phosphorylation. NDUFA10 knockdown only minimally affects CCCP-induced mitophagy in human cells, and NDUFA10 overexpression does not restore Parkin mitochondrial translocation upon PINK1 loss, indicating the rescue acts via Complex I activity rather than the Parkin/mitophagy pathway.\",\n      \"method\": \"Drosophila transgenic overexpression; RNAi screen in Drosophila cells; CCCP-induced mitophagy assay in human cells; Complex I activity assays; behavioral assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo and cell-based methods, genetic epistasis between PINK1 and parkin pathways established\",\n      \"pmids\": [\"25412178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CRISPR/Cas9 knockout of NDUFA10 in human cells results in loss of assembled, functional Complex I, demonstrating that NDUFA10 is strictly required for Complex I assembly; quantitative proteomics showed that loss of NDUFA10 destabilizes subunits in the same structural module.\",\n      \"method\": \"CRISPR/Cas9 gene editing in human cell lines; BN-PAGE; quantitative proteomics\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome editing with orthogonal biochemical and proteomic validation\",\n      \"pmids\": [\"27626371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NDUFA10 harbors a deoxyribonucleoside kinase (dNK) domain that tightly binds dGTP; mutation of this domain (E160A/R161A) reduces dGTP binding in vitro and lowers mitochondrial dGTP content by ~50% without disrupting Complex I assembly or activity, establishing NDUFA10 as the primary determinant of mitochondrial dGTP levels and linking oxidative metabolism to mitochondrial DNA maintenance.\",\n      \"method\": \"Site-directed mutagenesis in HEK-293T cells; in vitro dGTP-binding assay; measurement of mitochondrial dNTP pools by HPLC; BN-PAGE for Complex I assembly\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with in vitro binding assay and cellular dNTP quantification; assembly preserved as control\",\n      \"pmids\": [\"35739187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Benzo[a]pyrene (via its metabolite BPDE) downregulates NDUFA10 expression in mouse Leydig cells through PPARα activation, and NDUFA10-mediated mitochondrial dysfunction perturbs testosterone synthesis; NDUFA10 knockdown recapitulates mitochondrial impairment and steroidogenesis perturbation in TM3 cells.\",\n      \"method\": \"In vivo mouse model; transcriptome profiling; in vitro siRNA knockdown in TM3 cells; mitochondrial function assays; in silico toxicological analyses\",\n      \"journal\": \"Ecotoxicology and environmental safety\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — knockdown with functional readout (testosterone, mitochondrial morphology) in multiple systems, but mechanism inferred partly from expression data\",\n      \"pmids\": [\"36108438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CAV3 (caveolin-3) physically interacts with NDUFA10 as shown by co-immunoprecipitation; CAV3 overexpression reduces lysosomal degradation of NDUFA10, restores Complex I activity, and ameliorates mitochondrial dysfunction in diabetic cardiomyopathy models, while loss of CAV3 exacerbates NDUFA10 degradation and Complex I impairment.\",\n      \"method\": \"LC-MS/MS interactome; co-immunoprecipitation; cardiac-specific AAV overexpression in db/db mice; Complex I activity assays; mitochondrial function assays\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal Co-IP plus in vivo rescue, single lab\",\n      \"pmids\": [\"38671439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Neuroglobin (Ngb) physically interacts with NDUFA10 (confirmed by co-immunoprecipitation in MN9D cells); Ngb overexpression rescues Complex I activity, restores mitochondrial membrane potential and NAD+/NADH ratios, reduces ROS, and inhibits caspase-9-mediated apoptosis in an MPP+-induced Parkinson's disease cell model, while Ngb knockdown worsens these parameters.\",\n      \"method\": \"Co-immunoprecipitation; lentiviral overexpression and siRNA knockdown; ELISA-based Complex I activity; flow cytometry (apoptosis); MMP and ROS measurements\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus multiple functional readouts, single lab\",\n      \"pmids\": [\"39454716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PINK1 regulates ATP production by phosphorylating the Complex I subunit NdufA10; the PD-associated PINK1-G411S mutant shows increased kinase stability due to altered ATP-binding pocket rigidity (revealed by molecular dynamics), and enhances mitochondrial-linked functions including NdufA10 phosphorylation.\",\n      \"method\": \"Molecular dynamics simulation; biochemical characterization of PINK1 mutants; mitochondrial function assays\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 — preprint; structural inference from molecular dynamics with partial experimental validation\",\n      \"pmids\": [\"bio_10.1101_2024.06.28.601304\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Viral knockdown of NDUFA10 in the medial prefrontal cortex (mPFC) of mice reduces ATP levels and increases sevoflurane-induced burst suppression ratio and EEG suppression time, while exogenous ATP administration reverses these effects, establishing that NDUFA10-driven energy metabolism in the mPFC is required for normal cortical excitability under anesthesia.\",\n      \"method\": \"Site-specific viral knockdown; in vivo fiber-optic ATP recording; EEG recording; mRNA sequencing; ATP administration rescue\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-specific in vivo KD with defined electrophysiological and metabolic phenotype and ATP rescue\",\n      \"pmids\": [\"40415484\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFA10 is an accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that is strictly required for Complex I assembly and ubiquinone-reductive activity; its activity is regulated by PINK1-mediated phosphorylation at Ser-250, which is necessary for ubiquinone reduction, and its deoxyribonucleoside kinase (dNK) domain tightly sequesters mitochondrial dGTP to regulate dNTP pool homeostasis; NDUFA10 also interacts with CAV3 and neuroglobin, which protect it from lysosomal degradation and support Complex I-dependent ATP synthesis and mitochondrial membrane integrity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NDUFA10 is an accessory subunit of mitochondrial respiratory complex I that is essential for complex I assembly, stability, and NADH:ubiquinone oxidoreductase activity. Compound-heterozygous loss-of-function mutations in NDUFA10 cause isolated complex I deficiency with decreased complex I amount and disturbed assembly in patient tissues [PMID:21150889]. PINK1 phosphorylates NDUFA10 at Ser-250, and this modification is required for ubiquinone reduction by complex I; phosphomimetic NDUFA10 rescues complex I activity deficits and mitochondrial membrane potential in Pink1-knockout mouse cells and Drosophila [PMID:24652937], while overexpression of NDUFA10 itself can restore complex I function independently of Ser-250 phosphorylation [PMID:25412178]. Beyond its role in electron transport, NDUFA10 harbors a deoxyribonucleoside kinase domain that tightly binds dGTP and constitutes the primary reservoir of mitochondrial dGTP, a function separable from its complex I assembly and catalytic roles [PMID:35739187].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"The first evidence that NDUFA10 is post-translationally regulated within complex I came from identification of phosphoserine-59, establishing that accessory subunits of complex I are targets of phospho-signaling.\",\n      \"evidence\": \"Tandem mass spectrometry of purified bovine heart complex I with synthetic peptide confirmation\",\n      \"pmids\": [\"15848193\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Kinase responsible for Ser-59 phosphorylation not identified\",\n        \"Functional consequence of Ser-59 phosphorylation on complex I activity not tested\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery of two NDUFA10 isoforms and extensive post-translational modifications (33 modifications at 59 residues) suggested broad regulatory capacity beyond single-site phosphorylation.\",\n      \"evidence\": \"2D gel electrophoresis and tandem mass spectrometry of rat brain mitochondria\",\n      \"pmids\": [\"18442173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequences of the identified modifications (methylations, acetylations) not experimentally validated\",\n        \"Whether the D/N polymorphism at position 120 alters complex I function is unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing NDUFA10 as necessary for complex I integrity, compound-heterozygous patient mutations demonstrated that loss of NDUFA10 causes reduced complex I amount, activity, and disturbed assembly, linking the gene to isolated complex I deficiency.\",\n      \"evidence\": \"Patient fibroblast and muscle biochemistry; blue-native PAGE assembly analysis; genetic screening\",\n      \"pmids\": [\"21150889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether NDUFA10 loss is sufficient to cause disease or requires additional modifiers not determined\",\n        \"Mechanism by which NDUFA10 supports assembly versus catalytic activity not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Two studies resolved a key regulatory axis: PINK1 phosphorylates NDUFA10 at Ser-250, and this modification is required for ubiquinone reduction, while overexpression of NDUFA10 itself can bypass the phosphorylation requirement and restore complex I activity in PINK1-null animals independently of mitophagy.\",\n      \"evidence\": \"Phosphoproteomics of Pink1-knockout mouse complex I; phosphomimetic rescue across species (mouse cells, Drosophila); transgenic Drosophila overexpression with locomotion/complex I assays; human cell knockdown mitophagy assays\",\n      \"pmids\": [\"24652937\", \"25412178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether PINK1 directly phosphorylates NDUFA10 or acts through an intermediate kinase not definitively resolved by kinase-dead controls in the same system\",\n        \"Mechanism by which increased NDUFA10 protein levels bypass the need for Ser-250 phosphorylation is unclear\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A moonlighting function was uncovered: NDUFA10's deoxyribonucleoside kinase domain sequesters the majority of mitochondrial dGTP independently of complex I assembly and activity, revealing a dual role in electron transport and nucleotide metabolism.\",\n      \"evidence\": \"dNK domain mutagenesis (E160A/R161A) in HEK-293T cells; in vitro dGTP binding; mitochondrial dNTP pool quantification; complex I assembly/activity assays\",\n      \"pmids\": [\"35739187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether dGTP sequestration by NDUFA10 regulates mtDNA replication or repair is untested\",\n        \"Structural basis for dGTP binding within the assembled complex I not determined\",\n        \"Whether phosphorylation at Ser-250 or Ser-59 modulates dGTP binding is unknown\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Physical interaction partners were identified that modulate NDUFA10 stability and complex I function in disease contexts: CAV3 protects NDUFA10 from lysosomal degradation in cardiomyocytes, and neuroglobin interacts with NDUFA10 to restore complex I activity in a Parkinson's disease cell model.\",\n      \"evidence\": \"LC-MS/MS, co-immunoprecipitation, and cardiac-specific CAV3 overexpression in db/db mice; co-immunoprecipitation and lentiviral overexpression/knockdown in MN9D neuroblastoma cells\",\n      \"pmids\": [\"38671439\", \"39454716\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Neither interaction has been validated by a second independent laboratory\",\n        \"Direct binding domains on NDUFA10 for CAV3 and neuroglobin not mapped\",\n        \"Whether these interactions occur on assembled complex I or free NDUFA10 is unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"In vivo knockdown of NDUFA10 in mouse medial prefrontal cortex demonstrated that local complex I-dependent ATP production regulates cortical excitability, specifically anesthesia-induced burst suppression in aged brain.\",\n      \"evidence\": \"AAV-mediated site-specific knockdown; EEG burst suppression analysis; in vivo fiber-optic ATP recording\",\n      \"pmids\": [\"40415484\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the burst suppression phenotype reflects NDUFA10 loss specifically or general complex I deficiency not distinguished\",\n        \"Relevance to human anesthetic sensitivity not established\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how NDUFA10's dual functions in electron transport and dGTP sequestration are coordinated, whether its extensive post-translational modifications regulate these distinct roles, and what structural features within assembled complex I enable both activities.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of NDUFA10 within complex I that resolves the dNK domain occupancy with dGTP\",\n        \"Functional roles of the numerous methylation and acetylation sites remain uncharacterized\",\n        \"Whether NDUFA10 phosphorylation status affects mitochondrial dGTP pools is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\n      \"mitochondrial complex I\"\n    ],\n    \"partners\": [\n      \"PINK1\",\n      \"CAV3\",\n      \"NGB\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NDUFA10 is an accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that is strictly required for Complex I assembly, ubiquinone-reductive activity, and mitochondrial ATP production. PINK1 phosphorylates NDUFA10 at Ser-250, and this modification is necessary for Complex I ubiquinone reduction; phosphomimetic NDUFA10 rescues Complex I deficits, ATP synthesis, and synaptic transmission in PINK1-null Drosophila and patient-derived cells [PMID:24652937, PMID:25412178]. Beyond its Complex I structural role, NDUFA10 harbors a deoxyribonucleoside kinase domain that sequesters dGTP and serves as the primary determinant of mitochondrial dGTP levels, linking oxidative phosphorylation to mitochondrial DNA precursor homeostasis [PMID:35739187]. Compound-heterozygous loss-of-function mutations in NDUFA10 cause mitochondrial Complex I deficiency in patients [PMID:21150889].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification that NDUFA10 is a phosphoprotein established post-translational regulation of a Complex I accessory subunit, raising the question of which kinase(s) and which site(s) are functionally relevant.\",\n      \"evidence\": \"2D gel electrophoresis and tandem MS/MS on bovine heart mitochondrial Complex I, with synthetic peptide confirmation of phospho-Ser-59\",\n      \"pmids\": [\"15848193\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The responsible kinase was not identified\",\n        \"Functional consequence of Ser-59 phosphorylation on Complex I activity was not tested\",\n        \"Relevance of this site in non-bovine systems was unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that patient mutations in NDUFA10 cause deficient Complex I assembly and activity demonstrated that NDUFA10, although an accessory subunit, is indispensable for Complex I biogenesis.\",\n      \"evidence\": \"Biochemical analysis (BN-PAGE, activity assays, immunoblotting) of fibroblasts from a patient with compound-heterozygous NDUFA10 mutations\",\n      \"pmids\": [\"21150889\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single family study; genetic rescue was not performed\",\n        \"The specific assembly step blocked by NDUFA10 loss was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that PINK1 phosphorylates NDUFA10 at Ser-250 and that this event is required for ubiquinone reduction provided a direct mechanistic link between PINK1-associated Parkinson's disease and Complex I dysfunction.\",\n      \"evidence\": \"Phosphoproteomics of Complex I from Pink1−/− mouse tissues; phosphomimetic S250D rescue of Complex I activity, ATP synthesis, and neurotransmission in PINK1-null Drosophila and patient cells\",\n      \"pmids\": [\"24652937\", \"25412178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Ser-250 phosphorylation is the sole functional PINK1 target on Complex I or one of several\",\n        \"Structural basis of how phospho-Ser-250 enables ubiquinone reduction was not determined\",\n        \"Degree to which NDUFA10 rescue acts independently of the Parkin/mitophagy axis was debated across studies\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"CRISPR knockout confirmed that NDUFA10 is strictly required for Complex I assembly in human cells and that its loss destabilizes subunits within the same structural module, resolving ambiguity from patient studies.\",\n      \"evidence\": \"CRISPR/Cas9 knockout in human cell lines with BN-PAGE and quantitative proteomics\",\n      \"pmids\": [\"27626371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific assembly intermediate accumulates upon NDUFA10 loss was not fully resolved\",\n        \"Potential extra-Complex I functions were not addressed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of a deoxyribonucleoside kinase domain in NDUFA10 that tightly binds dGTP and controls ~50% of mitochondrial dGTP content revealed an unexpected moonlighting function linking oxidative metabolism to mtDNA precursor homeostasis.\",\n      \"evidence\": \"Site-directed mutagenesis (E160A/R161A) in HEK-293T cells; in vitro dGTP-binding assay; HPLC measurement of mitochondrial dNTP pools; BN-PAGE confirming intact Complex I assembly\",\n      \"pmids\": [\"35739187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether NDUFA10's dNK domain possesses catalytic kinase activity or acts solely as a sequestering/storage site\",\n        \"Impact of dGTP-binding mutations on mtDNA replication fidelity or copy number in vivo\",\n        \"Relationship between phosphorylation at Ser-250 and dGTP binding\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of CAV3 and neuroglobin as physical interactors of NDUFA10 that protect it from degradation and sustain Complex I function expanded the regulatory network controlling NDUFA10 stability in disease contexts (diabetic cardiomyopathy and Parkinson's models).\",\n      \"evidence\": \"Co-immunoprecipitation and LC-MS/MS interactomics; AAV-mediated CAV3 overexpression in db/db mouse hearts; Ngb overexpression/knockdown with Complex I activity and apoptosis readouts in MN9D cells\",\n      \"pmids\": [\"38671439\", \"39454716\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Binding interfaces on NDUFA10 for CAV3 and neuroglobin are unmapped\",\n        \"Whether these interactions occur on assembled Complex I or on free NDUFA10\",\n        \"Independent replication needed for both interactions\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"In vivo knockdown of NDUFA10 in mouse medial prefrontal cortex demonstrated that NDUFA10-dependent ATP production is required for normal cortical excitability, extending its physiological relevance to brain circuit function.\",\n      \"evidence\": \"Site-specific viral knockdown in mPFC; in vivo ATP fiber-optic recording; EEG; ATP rescue\",\n      \"pmids\": [\"40415484\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the phenotype is specific to NDUFA10 or generalizes to any Complex I subunit loss\",\n        \"Long-term neurological consequences of mPFC NDUFA10 depletion not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of how Ser-250 phosphorylation activates ubiquinone reduction, whether the dNK domain possesses catalytic kinase activity or functions purely as a dGTP-sequestering module, and how NDUFA10's dual roles in electron transfer and dNTP homeostasis are coordinated.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of NDUFA10 with bound dGTP or phospho-Ser-250 exists\",\n        \"Catalytic vs. sequestering function of the dNK domain unresolved\",\n        \"Coordination between phosphorylation state and dGTP binding not tested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2, 3, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [\n      \"Mitochondrial Complex I (NADH:ubiquinone oxidoreductase)\"\n    ],\n    \"partners\": [\n      \"PINK1\",\n      \"CAV3\",\n      \"NGB\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}